GLP-1 War Heats Up as Prices Slim Down & Powering the AI Age
Digest
The podcast discusses the intense competition in the GLP-1 drug market between Novo Nordisk and Eli Lilly, highlighting Novo Nordisk's recent price cuts in the US. It then shifts to Constellation Energy, detailing its strong earnings, the strategic reasons behind its delayed earnings call, and its acquisition of Kaopin Corporation, which expands its clean energy portfolio. The discussion also touches on the significant energy demand generated by AI and data centers, mentioning micro-nuclear reactor companies. Finally, it provides a market wrap-up with news on various other companies.
Outlines
GLP-1 Drug Competition and Constellation Energy's Strategy
The podcast begins by exploring the competitive landscape of GLP-1 drugs, focusing on the rivalry between Novo Nordisk and Eli Lilly, and Novo Nordisk's strategic price reductions. It then transitions to Constellation Energy, discussing its robust earnings, the rationale behind its unconventional earnings call, and its acquisition of Kaopin Corporation, emphasizing the expansion of its carbon-free electricity generation capabilities and its positioning to meet the growing energy demands of AI and data centers.
AI's Impact on Energy Demand and Market Wrap-up
This segment connects the surge in AI development and data center construction to the increasing demand for energy, including a look at micro-nuclear reactor companies. The episode concludes with a market wrap-up, featuring updates on Henry Shine, FactSet's partnership with Anthropic, Meta's deal with AMD, and the ongoing battle for Warner Brothers Discovery.
Keywords
GLP-1 drugs
Medications for type 2 diabetes and obesity, with key players Novo Nordisk and Eli Lilly in intense competition.
Constellation Energy (CEG)
Leading US provider of carbon-free electricity, operating nuclear, natural gas, and renewable facilities, expanding through acquisitions.
AI Data Centers
Facilities powering artificial intelligence, driving significant electricity demand and impacting the energy sector.
EV to EBITDA
A valuation metric used in mergers and acquisitions to assess company value relative to operating performance.
Micro Nuclear Reactors
Small-scale nuclear reactors designed for specific applications, representing advanced energy solutions for growing demand.
Kaopin Corporation Acquisition
Constellation Energy's acquisition expanding its geographic reach and strengthening its diverse energy generation portfolio.
Q&A
What are the "GLP-1 wars" and who are the main competitors?
The "GLP-1 wars" refer to the intense competition among pharmaceutical companies developing and marketing GLP-1 receptor agonist drugs for type 2 diabetes and obesity. Key players include Novo Nordisk and Eli Lilly.
Why did Constellation Energy decide not to hold a traditional earnings call?
Constellation Energy opted for a business and earnings outlook call due to potential upcoming policy changes, the State of the Union address, and the integration of its recent Kaopin acquisition.
How does the acquisition of Kaopin Corporation benefit Constellation Energy?
The acquisition expands Constellation Energy's geographic footprint and strengthens its position as a leading electricity generator, combining nuclear, natural gas, and geothermal resources.
What is the significance of the EV to EBITDA multiple in Constellation's acquisition of Kaopin?
Constellation acquired Kaopin at a lower EV/EBITDA multiple than its own trading multiple, suggesting the deal is accretive and can potentially increase Constellation's earnings per share.
How is the growth of AI impacting the energy sector?
The increasing demand for computational power for AI applications is driving massive investment in data centers, creating a significant surge in demand for electricity and benefiting energy companies.
Show Notes
Episode 130: Today, Ann digs into the Novo Nordisk vs Eli Lilly vs Pfizer news roundabout: with Novo’s share price dropping, now too are the list price of its popular obesity drugs - does that leave the entire sector vulnerable to… loss? Then we look at earnings from Constellation Energy, the largest operator of nuclear power plants in the U.S. - regulatory scrutiny builds as the sector grows in the AI age and residential customers see higher bills. Finally, we shine a light on Henry Schein and Factset and hit Parmount’s new salvo in the battle for Warner Brothers.
Subscribe to the Brew Markets newsletter: https://www.morningbrew.com/brew-mark...
Follow Brew Markets on social:
Instagram: instagram.com/brewmarkets
TikTok: tiktok.com/@brewmarkets
X: x.com/brewmarkets
Follow Ann Berry on social:
Instagram: instagram.com/annberry_nyc
X: x.com/AnnBerry_NYC
Listen to Brew Markets Here: swap.fm/l/9Qk4z73Z2nEwFiCB4qee
Watch Brew Markets Here: https://www.youtube.com/@BrewMarkets
00:00 Welcome to Brew Markets Daily
00:30 Inside The GLP-1 Wars
04:30 Earnings: Constellation Energy
15:00 Market Close
Learn more about GDX at vaneck.com/BrewGDX
Investing involves substantial risk and high volatility, including possible loss of principal. Visit vaneck.com or call 1-800-826-2333 to read and consider the prospectus, containing the investment objective, risks, and fees of the fund, carefully before
investing.
© Van Eck Securities Corporation, Distributor, a wholly owned subsidiary of Van Eck Associates Corporation.
The content shared on this podcast is for informational and entertainment purposes only and should not be considered financial, legal, or investment advice. Brew Markets, Morning Brew and their hosts are not licensed financial advisors. Listeners should conduct their own research and consult with qualified professionals before making any financial decisions or investments. The views expressed are those of the hosts and guests and do not necessarily reflect the views of Morning Brew or its affiliates. This podcast may include paid endorsements or sponsorships
Learn more about your ad choices. Visit megaphone.fm/adchoices
Table of contents
United States
